# Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission

> **NCT00053612** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 400 (—)

## Conditions studied

- HIV Infections
- Vitamin A Deficiency
- HIV Seronegativity

## Interventions

- **DRUG:** Vitamin A

## Key facts

- **NCT ID:** NCT00053612
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 400 (—)
- **Last updated:** 2016-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00053612

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00053612, "Vitamin A to Reduce HIV in Vaginal Secretions and Prevent Viral Transmission". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00053612. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*